梅花生物
(600873)
| 流通市值：307.00亿 | | | 总市值：307.00亿 |
| 流通股本：29.43亿 | | | 总股本：29.43亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,618,039,330.1 | 4,969,794,482.39 | 5,413,045,460.16 | 3,313,418,371.96 |
| 衍生金融资产 | 15,000 | 200,000 | 33,000 | 1,182,800 |
| 应收票据及应收账款 | 887,921,184.26 | 770,359,837.67 | 738,127,210.42 | 859,201,838.83 |
| 其中：应收票据 | 121,916,128.57 | 129,231,952.45 | 62,360,836.75 | 210,843,612.96 |
| 应收账款 | 766,005,055.69 | 641,127,885.22 | 675,766,373.67 | 648,358,225.87 |
| 应收款项融资 | 29,312,948.21 | 60,013,169.98 | 31,231,236.46 | 29,615,878.03 |
| 预付款项 | 393,751,276.98 | 252,089,088.23 | 120,317,457.17 | 218,032,888.82 |
| 其他应收款合计 | 107,759,866.93 | 51,384,535.97 | 44,399,713.17 | 62,820,220.02 |
| 其中:应收利息 | 1,968,750 | 1,575,000 | 1,181,250 | 787,500 |
| 存货 | 3,170,362,210.33 | 2,922,518,782.97 | 2,268,080,955.56 | 3,263,990,051.58 |
| 一年内到期的非流动资产 | 19,356,000 | 19,356,000 | 29,016,000 | 33,846,000 |
| 其他流动资产 | 212,560,944.94 | 289,218,469.96 | 309,885,823.75 | 311,728,613.26 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 9,608,806,563.4 | 9,507,311,168.5 | 9,434,691,396.99 | 8,840,203,051.13 |
| 非流动资产: | | | | |
| 债权投资 | 10,500,000 | 10,500,000 | 10,500,000 | 10,500,000 |
| 长期应收款 | 367,919.83 | 364,927.03 | 260,545.04 | 258,402.27 |
| 长期股权投资 | 18,348,923.11 | 18,942,230.64 | 18,170,635.83 | 20,362,234.26 |
| 其他权益工具投资 | 525,512,575 | 512,691,350 | 1,486,153,875.59 | 2,230,012,750.59 |
| 固定资产 | 11,184,309,271.23 | 11,428,700,356.22 | 11,629,762,535.68 | 9,666,396,072.6 |
| 在建工程 | 190,495,295.92 | 161,961,713.29 | 156,016,924.45 | 2,049,100,668.67 |
| 使用权资产 | 11,919,733.85 | 9,633,644.09 | 9,015,491.39 | 9,983,025.02 |
| 无形资产 | 1,170,883,589.25 | 1,075,943,303.26 | 1,084,827,130.97 | 1,094,338,321.51 |
| 商誉 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 | 11,788,911.79 |
| 长期待摊费用 | 113,093,002.63 | 104,076,824.93 | 106,166,687.96 | 94,889,405.98 |
| 递延所得税资产 | 92,487,464.52 | 106,143,010.15 | 106,113,800.24 | 127,164,859.48 |
| 其他非流动资产 | 495,434,065.78 | 209,122,415.35 | 180,169,973.67 | 238,259,122.18 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 13,825,140,752.91 | 13,649,868,686.75 | 14,798,946,512.61 | 15,553,053,774.35 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 23,433,947,316.31 | 23,157,179,855.25 | 24,233,637,909.6 | 24,393,256,825.48 |
| 流动负债: | | | | |
| 短期借款 | 2,137,941,502.77 | 1,543,869,058.69 | 1,758,531,079.51 | 1,463,436,916.77 |
| 衍生金融负债 | - | 250,000 | 17,258,400 | 12,125,000 |
| 应付票据及应付账款 | 2,379,685,663.5 | 2,608,628,848.71 | 2,527,850,675.28 | 2,371,965,604.5 |
| 其中：应付票据 | 1,005,113,214.2 | 1,183,031,652.44 | 893,222,294.37 | 760,588,317.69 |
| 应付账款 | 1,374,572,449.3 | 1,425,597,196.27 | 1,634,628,380.91 | 1,611,377,286.81 |
| 合同负债 | 633,186,469.08 | 892,931,047.76 | 1,131,018,588.61 | 811,699,146.39 |
| 应付职工薪酬 | 247,232,495.16 | 322,959,640.35 | 407,637,437.58 | 436,510,334.7 |
| 应交税费 | 175,817,765.85 | 256,472,526.55 | 174,665,854.93 | 128,961,628.56 |
| 其他应付款合计 | 254,483,173.29 | 249,853,910.4 | 271,639,707.14 | 475,452,352.37 |
| 应付股利 | 405,000 | 405,000 | 405,000 | 200,405,000 |
| 一年内到期的非流动负债 | 514,402,181.61 | 535,085,272.76 | 139,085,398.83 | 209,978,749.75 |
| 其他流动负债 | 99,417,145.7 | 118,688,728.75 | 327,283,396.96 | 375,282,990.71 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 6,442,166,396.96 | 6,528,739,033.97 | 6,754,970,538.84 | 6,285,412,723.75 |
| 非流动负债: | | | | |
| 长期借款 | 1,655,887,788.31 | 1,999,963,021.77 | 2,708,924,876.77 | 3,140,128,372.98 |
| 租赁负债 | 3,054,815.84 | 2,590,305.92 | 3,310,763.32 | 4,512,313.12 |
| 长期应付款 | 36,537,696.18 | 10,500,000 | 10,500,000 | 10,500,000 |
| 预计负债 | 31,663,389.07 | 45,888,616.17 | 30,888,616.17 | 30,888,616.17 |
| 递延收益 | 373,817,967.68 | 384,988,414.73 | 396,182,966.97 | 407,411,497.09 |
| 递延所得税负债 | 25,485,988.2 | 21,495,649.02 | 148,373,929.32 | 260,147,550.21 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 2,126,447,645.28 | 2,465,426,007.61 | 3,298,181,152.55 | 3,853,588,349.57 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 8,568,614,042.24 | 8,994,165,041.58 | 10,053,151,691.39 | 10,139,001,073.32 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,943,426,102 | 2,943,426,102 | 2,943,426,102 | 2,943,426,102 |
| 资本公积 | 1,032,707,760.4 | 1,032,707,760.4 | 1,032,707,760.4 | 1,032,707,760.4 |
| 减:库存股 | 638,328,051.81 | 576,775,719.27 | 367,030,998.09 | 135,000,042.9 |
| 其他综合收益 | 16,585,689.48 | 5,687,647.5 | 828,532,310.87 | 1,460,812,354.62 |
| 专项储备 | 5,220,632.05 | 3,952,446.88 | 4,045,082.67 | 3,173,603.87 |
| 盈余公积 | 1,326,294,444.3 | 1,326,294,444.3 | 1,142,518,851.07 | 1,142,518,851.07 |
| 未分配利润 | 10,179,426,697.65 | 9,427,722,131.86 | 8,596,287,109.29 | 7,806,617,123.1 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 14,865,333,274.07 | 14,163,014,813.67 | 14,180,486,218.21 | 14,254,255,752.16 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 14,865,333,274.07 | 14,163,014,813.67 | 14,180,486,218.21 | 14,254,255,752.16 |
| 负债和股东权益合计 | 23,433,947,316.31 | 23,157,179,855.25 | 24,233,637,909.6 | 24,393,256,825.48 |
| 公告日期 | 2024-04-09 | 2024-03-19 | 2023-10-19 | 2023-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |